Matinas Biopharma Holdings Inc
ASE:MTNB 4:00:00 PM EDT
| Market Cap (Intraday) | 87.88M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.41 |
| 50-Day MA | $0.50 |
| 200-Day MA | $0.59 |
Matinas Biopharma Holdings Inc Stock, ASE:MTNB
1545 Route 206 South, Suite 302, Bedminster, New Jersey 07921-9999
United States of America
Phone: +1.908.484.8805
Number of Employees: 34
Description
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.